Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters

Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial

(2021) Cassandra Aldrich et al.   VACCINE

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

(2021) Zijun Wang et al.   NATURE

Neutralizing Antibody Therapeutics for COVID-19

(2021) Aeron C. Hurt et al.   Viruses-Basel

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains

(2021) Rita E. Chen et al.   NATURE

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

(2021) Namit Chaudhary et al.   NATURE REVIEWS DRUG DISCOVERY

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

(2021) Meagan P. O’Brien et al.   NEW ENGLAND JOURNAL OF MEDICINE

Transient acquisition of cross-species infectivity during the evolution of SARS-CoV-2

(2021) Qi Chen et al.   National Science Review

Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2

(2021) Shihui Sun et al.   Nature Communications

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

(2020) Sin Fun Sia et al.   NATURE

A Thermostable mRNA Vaccine against COVID-19

(2020) Na-Na Zhang et al.   CELL

mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice

(2020) Lien Van Hoecke et al.   Molecular Therapy-Nucleic Acids

Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics

(2020) Pavlo Gilchuk et al.   Nature Biomedical Engineering

Characteristics of SARS-CoV-2 and COVID-19

(2020) Ben Hu et al.   NATURE REVIEWS MICROBIOLOGY

Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection

(2020) Jesse H. Erasmus et al.   Molecular Therapy-Methods & Clinical Development

Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2

(2020) Ling Zhu et al.   National Science Review

mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials

(2019) Robert A. Feldman et al.   VACCINE

A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection

(2019) Nurgun Kose et al.   Science Immunology

Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge

(2017) Norbert Pardi et al.   Nature Communications